http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013533238-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2011-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013533238-A |
| titleOfInvention | Semloparin for long-term prevention of lethal and / or pathological events in patients undergoing hip fracture surgery |
| abstract | The present invention relates to semlopaline or pharmaceutically acceptable thereof for long-term prevention of lethal and / or pathological events, more specifically venous thromboembolism and death, in patients undergoing hip fracture surgery Relates to the use of salt. |
| priorityDate | 2010-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.